4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-024622
Options or other derivatives
- President and CEO acquired 714,184 shares (grant or award)
- President and CEO returned 714,184 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Mack David Henry President and CEO | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −134,584 | 0 | D | ||
| Mack David Henry President and CEO | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −249,600 | 0 | D | ||
| Mack David Henry President and CEO | 2024-08-13 | Grant or award · Employee Stock Option (right to buy) | +384,184 | 384,184 | D | ||
| Mack David Henry President and CEO | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −330,000 | 0 | D | ||
| Mack David Henry President and CEO | 2024-08-13 | Grant or award · Employee Stock Option (right to buy) | +330,000 | 330,000 | D | ||
Loading xslF345X05/form4-10032024_081002.xml…